PUBLIC CONTRACT · 2022

4180123/2022 - Aq. Central U20 - Ustecinumab 45 mg (90 mg/ml ser pré-cheia 0.5 ml) sol inj

Contract value: €20,080.80
Signed on: 15 February 2022
Procedure: Ao abrigo de acordo-quadro (art.º 258.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 8935040

PUBLISHED SUBJECT

4180123/2022 - AQ. CENTRAL U20 - USTECINUMAB 45 MG (90 MG/ML SER PRÉ-CHEIA 0.5 ML) SOL INJ

WHO CONTRACTED

Parties involved

Contracting body: Centro Hospitalar Barreiro Montijo, E. P. E.
Awardee: Janssen-Cilag
Place of performance: Portugal, Setúbal, Barreiro
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: Janssen-Cilag · Tax ID 500189412

HOW MUCH AND WHEN

Values and timeline

Contract price: €20,080.80
Procedure base price: €20,080.80
Total effective price: €20,080.80
Publication date: 18 February 2022
Award date: 15 February 2022
Signing date: 15 February 2022
Performance period: 2 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 258.º)
Award criterion: Monofator
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 258.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 5789449

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts